in my DNA

Genentech's Avastin: An Undeserving Target for Politicians and the Media

Someone asked why not $55k per year instead of $100k+ per year. It costs Genentech between $500M and $800M to get a drug approved. Genentech then only has a limited time as patent owner before the generics can move in to make their versions. Genentech must also fund future research so they have new products. Genentech is a growth stock, not a dividend stock, and applies profits to further research.

One more thing to consider. Genentech offers assistance to patients that can not afford a Genentech product. Please check out the genentechaccessolution... website for more details.
Disclosure- Yes, I am a member of the Genentech Team and proud of it.